LifeVantage (NASDAQ:LFVN) Releases Quarterly Earnings Results, Misses Expectations By $0.07 EPS

LifeVantage (NASDAQ:LFVNGet Free Report) released its earnings results on Wednesday. The company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.21 by ($0.07), Zacks reports. LifeVantage had a net margin of 1.75% and a return on equity of 27.02%. The company had revenue of $48.93 million for the quarter. LifeVantage updated its FY 2025 guidance to 0.700-0.800 EPS.

LifeVantage Stock Down 11.8 %

LFVN stock opened at $7.77 on Friday. The business’s 50-day simple moving average is $7.24 and its 200 day simple moving average is $6.94. The company has a market cap of $98.69 million, a PE ratio of 27.75 and a beta of 0.81. LifeVantage has a twelve month low of $4.20 and a twelve month high of $9.14.

LifeVantage Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 17th. Investors of record on Monday, September 9th will be paid a $0.04 dividend. This represents a $0.16 annualized dividend and a dividend yield of 2.06%. The ex-dividend date of this dividend is Monday, September 9th. LifeVantage’s payout ratio is presently 57.14%.

About LifeVantage

(Get Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Read More

Earnings History for LifeVantage (NASDAQ:LFVN)

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.